Get started
Author

Rishi Puri

ORCID: 0000-0003-2402-6953
Observed ORCID: 0000-0003-2402-6953
OpenAlex ID: A5144263364
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al. · Cancer Discovery · 1
PDF
Establishment of Patient-Derived Xenotransplant and Cell Line Models for Canine B-Cell Lymphoma
2026 · Wilfred Leung, Timothy M. Pierpont, et al. · Cells
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S7 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Data from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Methods 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Works count: 26
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type